U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07619508) titled 'Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.' on May 23.
Brief Summary: Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Study Start Date: Feb. 10
Study Type: OBSERVATIONAL
Condition:
Obesity
Overweight
Intervention:
DRUG: Tirzepatide
Initiation of tirzepatide described in electronic health records is used as the exposure.
DRUG: S...